Document
type: Class

Academic Article
type: Class

4759792
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial

Continuant
type: Class

Entity
type: Class

individual
rights: termsOfUse
date: 2026-08-24T09:42:45
publisher: Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial
type: Document
label: RDF description of Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial - http://irises.unisr.it/resource/item/88433

Generically Dependent Continuant
type: Class

4759805
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial

Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial
type: Generically Dependent Continuant
type: Academic Article
type: Document
language: Inglese
type: Thing
most specific type: Academic Article
type: Article
type: Entity
type: Continuant
type: Information Content Entity
related by: 4759805
related by: 4759792

Article
type: Class

Inglese
type: Language

Information Content Entity
type: Class